AMAG Pharmaceuticals Inc

Visual Financials
Company Name: AMAG Pharmaceuticals Inc
Ticker Symbol: AMAG
CIK Number: 0000792977
WWW Address: http://www.amagpharma.com
CEO: William K. Heiden
No. of Employees: 545
Common Issue Type: CS
Business Description:AMAG Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of Feraheme® (ferumoxytol) Injection for Intravenous, or IV, use to treat iron deficiency anemia, or IDA.

 
Industry Information: DRUGS - Diagnostic Support [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 18.8 Up 0.6 17.9 26.0 18.3 18.95 18.00 1229442
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 658.9 35.0 0.00 -0.07 0.00 0.0 0.0 36.83 - 17.90
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close18.83$
PE Ratio - LTM0.0
Market Capitalisation658.9mil
Latest Shares Outstanding35.0mil
Earnings pS (EPS)-0.07$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate0.0%
Float25.5mil
Float as % of Shares Outstanding0.7%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.50%
Research & Devlopment (R&D) as % of Revenue0.10%
Gross Profit Margin78.0%
EBITDA Margin34.2%
Pre-Tax Profit Margin0.0%
Assets Turnover21.4%
Return on Assets (ROA)-0.1%
Return on Equity (ROE)-0.3%
Return on Capital Invested (ROCI)2.0%
Current Ratio2.3
Leverage Ratio (Assets/Equity)2.7
Interest Cover1.1
Total Debt/Equity (Gearing Ratio)1.16
LT Debt/Total Capital51.0%
Working Capital pS11.58$
Cash pS0.00$
Book-Value pS26.37$
Tangible Book-Value pS-22.75$
Cash Flow pS5.99$
Free Cash Flow pS5.83$
KEY FIGURES (LTM): Price info
Price/Book Ratio0.71
Price/Tangible Book Ratio0.00
Price/Cash Flow3.1
Price/Free Cash Flow3.2
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----4.0-51,179,2156,328,718
4 Weeks24.6517.9024.43-25.5-271,673,00135,133,025
13 Weeks25.2017.9023.33-22.0-241,065,78369,275,937
26 Weeks36.8317.9034.15-46.7-561,135,832143,114,864
52 Weeks36.8317.9020.95-13.1-28935,893235,845,131
YTD36.6017.90--46.3-531,231,265124,357,801
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
18.5719.1121.4925.6925.360.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.540.80.87
Income0.0
Dividend0.0
Capital SpendingNA
R&D7.24NA-7.95
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %15.515.539.4
Earnings %0.00.00.0
EPS %0.00.00.0
EPS $0.400.402.86
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio16.37
Current Ratio2.3
Quick Ratio (Acid Test)2.1
Liquidity Ratio (Cash)2.73
Receivables Turnover6.0
Average Collection Period60
Working Capital/Equity43.4
Working Capital pS11.81
Cash-Flow pS7.17
Free Cash-Flow pS7.01
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.76
Financial Leverage Ratio (Assets/Equity)1.2
Debt Ratio43.7
Total Debt/Equity (Gearing Ratio)1.16
LT Debt/Equity1.03
LT Debt/Capital Invested61.0
LT Debt/Total Liabilities89.1
Interest Cover0.0
Interest/Capital Invested3.38
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.27
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA7.41
Enterprise Value (EV)/Free Cash Flow1.40
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM0.71
Price/Cash Flow Ratio3.1
Price/Free Cash Flow Ratio - LTM3.2
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio-85.4
5-Y Low P/E Ratio-14.7
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS44.74
Current Liabilities pS14.50
Tangible Book Value pS - LTM-22.75
Book Value pS - LTM26.37
Capital Invested pS57.58
Cash pS - LTM0.00
Cash Flow pS - LTM5.99
Free Cash Flow pS - LTM5.83
Earnings pS (EPS)-0.07
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin45.25
Free Cash Flow Margin 5YEAR AVG13.03
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.0.2
Equity Productivity0.57
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.0.1
Capital Invested Productivity0.26
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.20
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin78.0
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM34.2
EBIT Margin - LTM15.5
Pre-Tax Profit Margin-0.1
Pre-Tax Profit Margin - 5YEAR AVRG.-0.1
Effective Tax Rate58.6
Effective Tax Rate - 5YEAR AVRG.13.9
EFFICIENCY RATIOS
Cash Conversion Cycle1,512,614
Revenue per Employee
Net Income per Employee
Average Collection Period1,512,614
Receivables Turnover6.0
Day's Inventory Turnover Ratio
Inventory Turnover3.0
Inventory/Sales7.0
Accounts Payble/Sales0.69
Assets/Revenue5.00
Net Working Capital Turnover1.31
Fixed Assets Turnover0.30
Total Assets Turnover0.2
Revenue per $ Cash1.94
Revenue per $ Plant21.75
Revenue per $ Common Equity0.57
Revenue per $ Capital Invested0.26
Selling, General & Adm/tive (SG&A) as % of Revenue47.0
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue12.4
R&D Expense as % of Revenue - 5YEAR AVRG.12.4

  
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V:us D:20170528 01:04:10